Roberta Faccio

7PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Molecular targetsAutoimmunityMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 11, 2026
Bone-derived Osterix+ osteolineage cells are a source of tumor-promoting myofibroblastic cancer-associated fibroblasts in breast cancer.

|Apr 21, 2026
Activation of the NLRP3 inflammasome in osteoclasts is suppressed by a Tmem178-dependent mechanism that restricts Ca2+ influx.

|Nov 24, 2025
Myofibroblastic CAFs arising from bone-resident osteoblast precursors retain an osteolineage signature and support breast cancer progression via Osterix-mediated signaling.

Giulia Furesi, Carisa Zeng, Emily M Eul

|Jan 30, 2025
Stroma-derived Dickkopf-1 contributes to the suppression of NK cell cytotoxicity in breast cancer.

Seunghyun Lee, Biancamaria Ricci, Jennifer Tran

|Aug 03, 2023
Tmem178 Negatively Regulates IL-1β Production Through Inhibition of the NLRP3 Inflammasome.

Kunjan Khanna, Hui Yan, Muneshwar Mehra

|Aug 07, 2020
Osterix-Cre marks distinct subsets of CD45- and CD45+ stromal populations in extra-skeletal tumors with pro-tumorigenic characteristics.

Biancamaria Ricci, Eric Tycksen, Hamza Celik

Pageof 2

Frequent Collaborators

3 joint publications

Deborah J Veis

2 joint publications

Hui Yan

2 joint publications

Maxim N Artyomov

2 joint publications

Gabriel Mbalaviele